Wikipedia -WSS

Wikipedia

author：Wikipedia 2025-10-02 05:01:16 - browse：82446

gantenerumab Alzheimer's disease Roche — Sebastien Bozon/AFP via Getty Images

LONDON — The booming obesity market is attracting another player, as pharma giant Roche said Monday it was acquiring Carmot Therapeutics and the company’s line of weight loss drug candidates for $2.7 billion upfront.

The deal for Carmot, which is based in Berkeley, Calif., includes additional milestone payments of up to $400 million. Carmot is privately held, though it had filed paperwork last month for an initial public offering.

As part of the deal, Roche is gaining three experimental obesity medicines from Carmot, which are in Phase 1 or Phase 2 testing, as well as preclinical programs. While two are injectable treatments, one is being developed as an oral drug. They all target GLP-1 hormone receptors, while two are also designed to work via receptors for another hormone called GIP.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Sports medicine is finally prioritizing gender equality
Next article： The aspartame in Diet Coke probably isn’t giving you cancer

hotspot

WSS

Goldman Sachs launches $650M fund for life science investments

UCB departs biotech trade group BIO

The U.S. needs a new definition of substance use “recovery”

Nevada Republican Sam Brown launching another Senate bid, teeing up marquee race

White House finalizes ITC's import ban of latest Apple Watches

JPM 2024 Day 3: Biotech Updates from Verve, Roivant, etc

hotspot

Wikipedia

hotspot

Apple is now the first public company to be valued at $3 trillion

How a scoliosis diagnosis changed the life of one young dancer

Continuity nursing helped my family in our darkest PICU moments

White House finalizes ITC's import ban of latest Apple Watches

Hepatitis C has a cure — but many Americans still lack access to it

3 medical device trends to watch in 2024

New air purifier tech could be key to improving indoor air quality

Swim instructor mom warns parents not to buy blue swimsuits for kids

In age of alternative facts, a scholarly course on calling out crap

The aspartame in Diet Coke probably isn’t giving you cancer

knowledge

JPM 2024 Day 3: Biotech Updates from Verve, Roivant, etc

Tulsa Race Massacre survivors and attorneys respond to dismissal of lawsuit

How a scoliosis diagnosis changed the life of one young dancer

Swim instructor mom warns parents not to buy blue swimsuits for kids

The FDA must approve intranasal treatments for anaphylaxis

AdventHealth escalates lawsuit against insurance vendor Multiplan

hotspot

Wikipedia

hotspot

explore